News : pharmakodex

View:
 

Found press releases

 

Orexo AB (publ.) – Year-end Report January-December 2009

Uppsala, February 17, 2010

Orexo AB (publ) –
Year-end Report January–December 2009



Key events during the year
• Net revenues totaled MSEK 236.1 (233.3).
• The loss after tax was MSEK 98.1 (loss: 103.1).
• The loss per share amounted to a loss of SEK 4.32 (loss: 4.77).
• Cash and cash equivalents at year-end totaled MSEK 87.4 (188.2).
• Abstral was launched in UK, Germany, France, Spain and Greece.
• In March,...

Orexo acquires a UK drug delivery company

Orexo AB (publ) (Orexo) (NASDAQ-OMX:ORX) today announced the acquisition of PharmaKodex Ltd (PharmaKodex), a UK drug delivery company with expertise in the reformulation and development of prescription and consumer health medicines containing small molecule drugs. The company has a number of ready to partner preclinical and early clinical projects focused on improving oral, sublingual and transdermal medication....